pentylenetetrazol
Approved
Jun 1, 1934
Pentylenetetrazol (PTZ), also known as pentylenetetrazole, pentetrazol (INN), and pentamethylenetetrazol, is a drug formerly used as a circulatory and respiratory stimulant. High doses cause convulsions, as discovered by Hungarian-American neurologist and psychiatrist Ladislas J. Meduna in 1934. It has been used in convulsive therapy, and was found to be effective in treating depression, but side effects such as uncontrolled seizures were difficult to avoid. In 1939, pentylenetetrazol was replaced by electroconvulsive therapy, which is easier to administer, as the preferred method for inducing seizures in England's mental hospitals. In the US, Pentylenetetrazol's approval by the Food and Drug Administration (FDA) was revoked in 1982. It is used in Italy as a cardio-respiratory stimulant in combination with dihydrocodeine in a cough suppressant drug. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Timeline
1930s
- Jun 1, 1934
Evidence of US Marketing
Indications
Approved for
Mechanism of action
- GABA A receptor alpha-1/beta-1/gamma-2ANTAGONIST
GABA A receptor alpha-1/beta-1/gamma-2 antagonist
Approval history
- approvedJun 1, 1934
Chemistry & pharmacology
SMILES
C1CCc2nnnn2CC1- Mol. weight
- 138.17 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPentylenetetrazol ↗
- ChEMBLCHEMBL116943 ↗
Also known as
- metrazol
- metrazol
- pentylenetetrazol
- pentylenetetrazol
- pentylenetetrazol